| Results identify miR-134 as a novel RTK-regulated tumor-suppressive hub that mediates RTK and RTK-inhibitor effects on GBM malignancy by controlling KRAS and STAT5B. | GBM, |
| miR-134 may function as a tumor suppressor in cell proliferation by targeting KRAS in renal cell carcinoma cells. | kidney, |
| Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma | osteosarcoma, |
| Findings indicate that miR 134 may act as a tumor suppressor in colorectal carcinoma. | colorectal, |
| miR-134 may function as a tumor suppressor in glioma | glioma, |
| these data indicate that miRs-134 and -370 are potential tumour suppressor miRNAs and could play a fundamental role in suppressing colorectal cancer tumorigenesis through their ability to co-ordinately regulate EGFR signalling cascade by independently targeting EGFR and PIK3CA. | colorectal, |
| MicroRNA-134 functions as a tumor suppressor gene in gastric cancer | gastric, |
| MiR-134 could play an important role as a tumor suppressor relying on its direct translational attenuation of Nanog | None |